IMN || Nephrology & Urology

SLGT2 inhibitors show promise in renal protection

Posted on: 16/05/2014 - 19:40

LAS VEGAS – In the opinion of Dr. David Cherney, it’s not uncommon for physicians to feel grim about the limited efficacy of available agents to treat chronic kidney disease in patients with type 1...

Field of Interest: Endocrinology
Type: News Item

Interferon-free regimen improves response in HCV

Posted on: 05/05/2014 - 21:25

CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...

Field of Interest: Gastroentero...
Type: News Item

Interferon-free regimen improves response in HCV

Posted on: 05/05/2014 - 21:25

CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...

Field of Interest: Infectious diseases
Type: News Item

Chronic kidney disease may raise cancer risk

Posted on: 28/04/2014 - 16:00

LAS VEGAS – Patients with chronic kidney disease appear to be at increased risk for cancer, a study showed. A retrospective analysis of data on 31,896 participants in <link...

Field of Interest: Oncology
Type: News Item

Pulsatile tinnitus looms large in fibromuscular dysplasia

Posted on: 18/04/2014 - 20:30

WASHINGTON – Think cerebrovascular fibromuscular dysplasia in a middle-aged woman who presents with a complaint of pulsatile tinnitus. That’s the take-home message from a new analysis of the <link...

Field of Interest: Cardiology
Type: News Item

VIDEO: Exploring SYMPLICITY’s failure, Part 2

Posted on: 04/04/2014 - 18:35

WASHINGTON – Far from being doomed after the failure SYMPLICITY HTN-3, renal denervation for refractory hypertension will continue to be explored. But it can’t go very far without finding a way to...

Field of Interest: Cardiology
Type: News Item

VIDEO: What explains SYMPLICITY HTN-3’s failure?

Posted on: 29/03/2014 - 21:55

WASHINGTON  – What can explain the failure of SYMPLICITY HTN-3? After clinical success in reducing blood pressure by 20-30 mm HG in patients with resistant hypertension, the renal denervation...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness